Working… Menu
Trial record 18 of 572 for:    ESCITALOPRAM AND Disorders

A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03924323
Recruitment Status : Recruiting
First Posted : April 23, 2019
Last Update Posted : April 30, 2021
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 2, 2021
Estimated Study Completion Date : July 2, 2021